Hutcherson DA - Search Results

1

Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.

Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Zhang H, et al. Among authors: hutcherson da. Biol Blood Marrow Transplant. 2012 Aug;18(8):1287-94. doi: 10.1016/j.bbmt.2012.02.006. Epub 2012 Feb 25. Biol Blood Marrow Transplant. 2012. PMID: 22370160 Free article.

2

Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.

Santos EC, Sessions J, Hutcherson D, Flowers C, Langston A, Waller EK. Santos EC, et al. Biol Blood Marrow Transplant. 2007 Jun;13(6):746-7. doi: 10.1016/j.bbmt.2007.02.006. Biol Blood Marrow Transplant. 2007. PMID: 17531785 Free article. No abstract available.

3

Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.

Davis CC, Cohen JB, Shah KS, Hutcherson DA, Surati MJ, Valla K, Panjic EH, Handler CE, Switchenko JM, Flowers CR. Davis CC, et al. Among authors: hutcherson da. Clin Lymphoma Myeloma Leuk. 2015 May;15(5):270-7. doi: 10.1016/j.clml.2014.12.011. Epub 2014 Dec 31. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25704479 Free PMC article.

4

Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Jo Lechowicz M, Waller EK. Lonial S, et al. Leuk Lymphoma. 2006 Oct;47(10):2155-62. doi: 10.1080/10428190600774923. Leuk Lymphoma. 2006. PMID: 17071490 Clinical Trial.

5

Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphoma.

Sinha R, Shenoy PJ, King N, Lechowicz MJ, Bumpers K, Hutcherson D, Arellano M, Langston A, Kaufman J, Heffner LT Jr, Waller EK, Nooka A, Flowers CR, Lonial S. Sinha R, et al. Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):657-63. doi: 10.1016/j.clml.2013.05.007. Epub 2013 Oct 2. Clin Lymphoma Myeloma Leuk. 2013. PMID: 24094894

6

Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.

Langston AA, Redei I, Caliendo AM, Somani J, Hutcherson D, Lonial S, Bucur S, Cherry J, Allen A, Waller EK. Langston AA, et al. Blood. 2002 Feb 1;99(3):1085-8. doi: 10.1182/blood.v99.3.1085. Blood. 2002. PMID: 11807018 Free article.

7

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.

McPherson ME, Hutcherson D, Olson E, Haight AE, Horan J, Chiang KY. McPherson ME, et al. Bone Marrow Transplant. 2011 Jan;46(1):27-33. doi: 10.1038/bmt.2010.60. Epub 2010 Mar 22. Bone Marrow Transplant. 2011. PMID: 20305698

8

Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.

Aldrete SD, Kraft CS, Magee MJ, Chan A, Hutcherson D, Langston AA, Greenwell BI, Burd EM, Friedman-Moraco R. Aldrete SD, et al. Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12649. Transpl Infect Dis. 2017. PMID: 27943501

9

High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.

Arellano M, Winton E, Pan L, Lima L, Tighiouart M, Bhalla K, Heffner LT, Neely J, Hutcherson D, McLemore M, Langston A, Khoury HJ. Arellano M, et al. Cancer. 2012 Jan 15;118(2):428-33. doi: 10.1002/cncr.26290. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717443 Free article.

10

Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy.

Hutcherson DA, Gammon DC, Bhatt MS, Faneuf M. Hutcherson DA, et al. Pharmacotherapy. 2006 Feb;26(2):242-7. doi: 10.1592/phco.26.2.242. Pharmacotherapy. 2006. PMID: 16466328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page